Profile data is unavailable for this security.
About the company
Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.
- Revenue in USD (TTM)81.06m
- Net income in USD-55.55m
- Incorporated2010
- Employees214.00
- LocationSight Sciences Inc4040 Campbell Ave,, Suite 100MENLO PARK 94025United StatesUSA
- Phone+1 (415) 889-0550
- Fax+1 (302) 655-5049
- Websitehttps://www.sightsciences.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CVRx Inc | 42.09m | -52.01m | 183.13m | 200.00 | -- | 2.76 | -- | 4.35 | -2.48 | -2.48 | 2.01 | 3.07 | 0.3678 | 0.6781 | 5.64 | 210,430.00 | -45.45 | -- | -48.95 | -- | 84.45 | -- | -123.58 | -- | 10.87 | -21.11 | 0.3064 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Semler Scientific Inc | 68.18m | 20.58m | 186.46m | 92.00 | 10.09 | 2.54 | 8.80 | 2.73 | 2.63 | 2.63 | 8.71 | 10.43 | 0.9688 | 15.28 | 13.62 | 741,130.40 | 29.25 | 38.83 | 32.24 | 44.41 | 89.76 | 90.22 | 30.19 | 32.58 | 10.56 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Stereotaxis Inc | 26.77m | -22.06m | 190.54m | 122.00 | -- | 11.49 | -- | 7.12 | -0.2737 | -0.2737 | 0.3318 | 0.2708 | 0.5617 | 1.46 | 6.01 | 219,434.40 | -43.46 | -25.02 | -61.11 | -34.12 | 55.51 | 67.57 | -77.37 | -41.90 | 1.88 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Butterfly Network Inc | 65.90m | -133.70m | 194.31m | 225.00 | -- | 0.8703 | -- | 2.95 | -0.6507 | -0.6507 | 0.3209 | 1.06 | 0.1826 | 0.7376 | 4.69 | 292,888.90 | -37.04 | -- | -42.70 | -- | 25.58 | -- | -202.88 | -- | 3.57 | -- | 0.00 | -- | -10.21 | -- | 20.76 | -- | -- | -- |
| Akoya Biosciences Inc | 96.63m | -63.32m | 196.87m | 330.00 | -- | 3.64 | -- | 2.04 | -1.48 | -1.48 | 2.18 | 1.09 | 0.5423 | 2.49 | 7.23 | 292,827.30 | -35.53 | -- | -44.59 | -- | 58.27 | -- | -65.53 | -- | 2.94 | -10.94 | 0.5882 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Orchestra Biomed Holdings Inc | 2.76m | -49.12m | 198.56m | 56.00 | -- | 2.92 | -- | 71.94 | -1.49 | -1.49 | 0.0832 | 1.90 | 0.0289 | 0.8815 | 28.31 | 49,285.71 | -51.49 | -- | -61.01 | -- | 93.26 | -- | -1,779.71 | -- | 7.94 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| Utah Medical Products, Inc. | 50.22m | 16.64m | 241.50m | 169.00 | 14.71 | 1.90 | 10.52 | 4.81 | 4.57 | 4.57 | 13.81 | 35.35 | 0.3873 | 2.19 | 11.25 | 297,183.40 | 12.83 | 12.69 | 13.38 | 13.19 | 59.81 | 61.57 | 33.12 | 30.51 | 20.53 | -- | 0.00 | 37.05 | -3.93 | 3.64 | 0.9834 | 1.65 | 9.71 | 1.86 |
| AngioDynamics, Inc. | 324.01m | -192.37m | 243.53m | 815.00 | -- | 1.12 | -- | 0.7516 | -4.78 | -4.78 | 8.10 | 5.41 | 0.7468 | 2.66 | 6.46 | 397,555.80 | -44.34 | -9.12 | -54.02 | -10.17 | 50.17 | 54.23 | -59.37 | -19.48 | 1.62 | -- | 0.00 | -- | 7.13 | 5.30 | -97.54 | -- | 3.55 | -- |
| AxoGen Inc | 159.01m | -21.72m | 256.98m | 426.00 | -- | 2.65 | -- | 1.62 | -0.5070 | -0.5070 | 3.71 | 2.22 | 0.8108 | 1.63 | 6.72 | 373,267.60 | -11.07 | -13.92 | -12.85 | -15.84 | 78.46 | 79.74 | -13.66 | -20.28 | 2.14 | -- | 0.3277 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Edap Tms SA (ADR) | 64.80m | -22.71m | 272.34m | 307.00 | -- | 4.46 | -- | 4.20 | -0.6141 | -0.6141 | 1.75 | 1.65 | 0.6272 | 2.68 | 3.86 | 211,087.10 | -21.98 | -6.62 | -29.54 | -9.22 | 40.40 | 43.23 | -35.05 | -9.59 | 2.30 | -27.44 | 0.1045 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
| Senseonics Holdings Inc | 22.39m | -60.39m | 275.02m | 132.00 | -- | 7.68 | -- | 12.28 | -0.1023 | -0.1023 | 0.0387 | 0.1385 | 0.1418 | 2.40 | 6.41 | 169,621.20 | -38.24 | -73.65 | -45.21 | -106.97 | 13.81 | -40.41 | -269.73 | -649.86 | 7.03 | -- | 0.3593 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| Sight Sciences Inc | 81.06m | -55.55m | 277.99m | 214.00 | -- | 2.29 | -- | 3.43 | -1.14 | -1.14 | 1.67 | 2.45 | 0.4269 | 1.70 | 5.51 | 378,761.70 | -29.26 | -38.78 | -31.77 | -42.20 | 85.34 | 80.74 | -68.53 | -105.14 | 12.65 | -10.59 | 0.2201 | -- | 13.63 | 60.84 | 35.59 | -- | 6.77 | -- |
| Bioventus Inc | 502.76m | -122.57m | 313.50m | 970.00 | -- | 1.76 | -- | 0.6236 | -1.97 | -2.93 | 8.06 | 2.25 | 0.4552 | 2.14 | 4.10 | 448,889.30 | -14.34 | -- | -18.91 | -- | 62.87 | 70.26 | -31.51 | -9.18 | 0.9443 | 0.3731 | 0.6354 | -- | 18.85 | 11.89 | -919.12 | -- | -- | -- |
| Tactile Systems Technology Inc | 274.42m | 28.52m | 343.09m | 992.00 | 12.16 | 1.76 | 9.79 | 1.25 | 1.19 | 1.19 | 11.90 | 8.20 | 1.02 | 6.02 | 5.60 | 276,636.10 | 10.63 | 0.9015 | 13.23 | 1.09 | 49.95 | 49.10 | 10.39 | 0.8309 | 2.99 | -- | 0.1308 | 0.00 | 11.20 | 13.81 | 259.60 | 33.91 | -23.62 | -- |
| Pulmonx Corp | 72.99m | -58.73m | 364.06m | 279.00 | -- | 3.27 | -- | 4.99 | -1.54 | -1.54 | 1.91 | 2.87 | 0.399 | 1.14 | 7.81 | 261,627.20 | -32.11 | -26.27 | -35.87 | -28.97 | 74.31 | 71.95 | -80.46 | -93.76 | 6.14 | -- | 0.252 | -- | 27.98 | 27.98 | -3.26 | -- | 20.62 | -- |
| Zynex Inc | 188.68m | 8.17m | 368.47m | 1.10k | 51.03 | 11.29 | 29.13 | 1.95 | 0.2261 | 0.2261 | 5.39 | 1.02 | 1.59 | 2.52 | 6.56 | 171,530.00 | 6.89 | 14.58 | 8.41 | 17.52 | 80.22 | 79.62 | 4.33 | 10.44 | 2.87 | 7.24 | 0.6381 | -- | 16.54 | 42.01 | -42.91 | 0.3741 | 2.19 | -- |
Data as of May 03 2024. Currency figures normalised to Sight Sciences Inc's reporting currency: US Dollar USD
26.33%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BofA Securities, Inc.as of 31 Dec 2023 | 3.00m | 6.06% |
| UBS Securities LLCas of 31 Dec 2023 | 2.89m | 5.82% |
| Jackson Square Partners LLCas of 31 Dec 2023 | 1.63m | 3.29% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 1.43m | 2.89% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 1.37m | 2.76% |
| JPMorgan Investment Management, Inc.as of 31 Dec 2023 | 1.02m | 2.05% |
| Geode Capital Management LLCas of 31 Dec 2023 | 565.09k | 1.14% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 441.64k | 0.89% |
| D. E. Shaw & Co. LPas of 31 Dec 2023 | 404.84k | 0.82% |
| Jacobs Levy Equity Management, Inc.as of 31 Dec 2023 | 300.51k | 0.61% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
